Brief: Impel Neuropharma Announces $100 Mln Royalty And Debt Financing Agreement With Oaktree
17/03/2022 13:30
March 17 (Reuters) - Impel Neuropharma Inc IMPL.O :
* IMPEL NEUROPHARMA ANNOUNCES $100 MILLION ROYALTY AND DEBT
FINANCING AGREEMENT WITH OAKTREE
* IMPEL NEUROPHARMA INC - TRANSACTION PROVIDES IMMEDIATE,
NON-DILUTIVE CAPITAL TO FURTHER SUPPORT COMMERCIALIZATION OF
TRUDHESA
* IMPEL NEUROPHARMA INC - $100 MILLION IN GROSS PROCEEDS TO
BE
FUNDED AT CLOSE, EXTENDING ESTIMATED CORPORATE CASH RUNWAY INTO
2024
Source text for Eikon: ID:nGNX3wbKy9
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq